to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
With immigrants in more than 40 percent of the cancer researcher slots at America’s top cancer institutes, these scientists are playing an integral role in improving cancer survival rates in the United States, according to a Kauffman Foundation-funded National Foundation for American Policy report released last month.
As a life science entrepreneur, you surely have ideas on how changing legal rules and policies could promote innovation and accelerate U.S. economic growth. The Kauffman Foundation, seeking suggestions on how to jumpstart the struggling economy, convened America’s leading legal scholars and social scientists to offer their thoughts.
With U.S. healthcare costs rising about 2.5 percent faster than inflation, there’s an urgent need to improve productivity and quality in American healthcare. A Kauffman Foundation report found that open access to medical data could help find that cost-benefit balance.
Because life sciences entrepreneurship thrives on harnessing new technologies, spurring innovation, and growing companies, the Kauffman Foundation met in 2003 with the Panel of Advisors on the Life Sciences to help advance those goals.
More than 6 percent of Inc. 500 firms work in the health and drug space, making it the No. 5 industrial sector for these fast-growing companies from 2005 to 2010. But these medical innovators aren’t all concentrated in the Silicon Valley.
The Myelin Repair Foundation, Ewing Marion Kauffman Foundation, Pioneer Portfolio of the Robert Wood Johnson Foundation, and the Scott Cook & Signe Ostby Foundation are offering an interactive Webinar to discuss a new drug development model with the potential to cut years from the drug...
Where do millionaires get their fortunes? Passed down from generation-to-generation through family inheritance? Wrong. A new report from Barclay’s examines recent shifts in the creation of wealth and finding that in established economies long-established models of inheritance have given way to entrepreneurial activity as the preeminent source.
It’s no secret that the economy is in sickbay. But healthcare entrepreneurs looking for a big transfusion of cash shouldn’t look to an initial public offering.
On a recent appearance on MSNBC, Senate Small Business & Entrepreneurship Committee chair Mary Landrieu talked about easing the flow of credit and other efforts in Washington to help small businesses. Visit msnbc.com for Breaking News, World News, and News about the Economy
A recent blog by Dan Isenberg from Babson College argues that there has been too much focus on startups around the world and that “infinitely more important is to embed scale-up.” Of course, Dan has a point in that I frequently hear leaders outside the United States lament their lack of billion dollars firms, but I think we are far from the point when we can stop advocating for better support for new starts. Not only is most of the world still focused on size not age of firms—talking “SMEs”—but we still do not know enough about the science of startups and how to best support those that want to scale. As with kids—to play along with Isenberg’s analogy—we have to help firms start better if they are to scale later in life and now is not the time to pull back the throttle on legitimizing founders and startups as a centrepiece of that economy policy.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.